Promoting Peace of Mind in Work Comp By Barry Thompson To provide peace of mind to an injured worker -- and reduce the number of big claims -- employers should address 10 questions right away.
Stop Being Clueless About Workers' Comp By Rebecca Shafer Clueless employers don't understand that they can control their workers' comp costs -- and not just complain about them.
9 Key Factors for Drug Formularies By Mark Pew Drug formularies should be all about better outcomes for patients, not cost. Take care of the injured worker, and everyone else wins, too.
Don't Drink the Kool-Aid on Opt-Out By David DePaolo A workers' comp case in Oklahoma demonstrates the true intent of at least ONE opt-out participant: to stick it to the worker.
The Best of Claims, the Worst of Claims By Barry Thompson Two workers' comp claims show how little control we have over an employee’s attitude -- and how important it is in determining the outcome.
Guidelines for Marijuana at Work By Mark Pew Marijuana use at work is a very complicated issue -- and not just because many state laws conflict with the federal ban on marijuana.
Rethinking Underwriting for Commercial Lines By Deb Smallwood Exciting technologies are delivering automation directly to the underwriter's desk.
Solution to High-Cost Indemnity Payments? By Dave Stair As firms struggle to manage costs for indemnity payments in workers' comp, card-based systems can make the process more efficient.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.